CAS 1903008-80-9

Fórmula: C30H34N8O3

InChI: InChI=1S/C30H34N8O3/c1-5-28(39)32-23-17-24(26(40-4)18-25(23)37-13-15-41-16-14-37)33-30-31-12-11-27(34-30)38-20-22(19-36(2)3)29(35-38)21-9-7-6-8-10-21/h5-12,17-18,20H,1,13-16,19H2,2-4H3,(H,32,39)(H,31,33,34)

Clave InChI: RRMJMHOQSALEJJ-UHFFFAOYSA-N

SMILES: CN(C)CC1=CN(N=C1C2=CC=CC=C2)C3=NC(=NC=C3)NC4=C(C=C(C(=C4)NC(=O)C=C)N5CCOCC5)OC

Lazertinib

CAS: 1903008-80-9

Fórmula: C₃₀H₃₄N₈O₃

Pureza: 97%

Forma y color: Solid

Peso molecular: 554.6428

Ref: IN-DA01EB29

Lazertinib

CAS: 1903008-80-9

Fórmula: C₃₀H₃₄N₈O₃

Peso molecular: 554.66

Ref: 4Z-L-238001

Lazertinib

CAS: 1903008-80-9

Lazertinib

Fórmula: C₃₀H₃₄N₈O₃

Pureza: ≥98%

Peso molecular: 554.64

Ref: 54-BUP12851

N-(5-((4-(4-((Dimethylamino)Methyl)-3-Phenyl-1H-Pyrazol-1-Yl)Pyrimidin-2-Yl)Amino)-4-Methoxy-2-Morpholinophenyl)Acrylamide

CAS: 1903008-80-9

N-(5-((4-(4-((Dimethylamino)Methyl)-3-Phenyl-1H-Pyrazol-1-Yl)Pyrimidin-2-Yl)Amino)-4-Methoxy-2-Morpholinophenyl)Acrylamide

Fórmula: C₃₀H₃₄N₈O₃

Pureza: 97%

Peso molecular: 554.64

Ref: 54-OR1024173

Lazertinib

CAS: 1903008-80-9

N-(5-((4-(4-((Dimethylamino)methyl)-3-phenyl-1H-pyrazol-1-yl)pyrimidin-2-yl)amino)-4-methoxy-2-morpholinophenyl)acrylamide

Fórmula: C₃₀H₃₄N₈O₃

Pureza: 97%

Peso molecular: 554.64

Ref: IN-DG00794029

Lazertinib

CAS: 1903008-80-9

Lazertinib (GNS-1480) is a potent, selective, irreversible EGFR-TKI; IC50: 1.7-76 nM for various EGFR mutations.

Fórmula: C₃₀H₃₄N₈O₃

Pureza: 98.7% - 99.90%

Forma y color: Yellow Solid

Peso molecular: 554.6428

Ref: TM-T4485

Lazertinib

Producto controlado

CAS: 1903008-80-9

Fórmula: C₃₀H₃₄N₈O₃

Forma y color: Neat

Peso molecular: 554.643

Ref: TR-L215260

Lazertinib

CAS: 1903008-80-9

Lazertinib is a potent tyrosine kinase inhibitor with inhibitory properties against cancer cells. Lazertinib has been shown to have inhibitory effects on epidermal growth factor receptor (EGFR) and HER2/neu receptors, which are important for the growth of solid tumours. This drug inhibits the phosphorylation of these receptors, thereby blocking their downstream signalling pathways that promote cancer cell proliferation. Lazertinib also inhibits the activity of other tyrosine kinases including c-MET, AXL and RET, which may be important for inhibiting cancer cell growth in patients with autoimmune diseases.

Fórmula: C₃₀H₃₄N₈O₃

Pureza: Min. 95%

Peso molecular: 554.64 g/mol

Ref: 3D-DBD00880